Journal for ImmunoTherapy of Cancer

Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients
Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A. Staerkel, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Beth A. Chasen, Jennifer A. Wargo, Victor G. Prieto, Rodabe N. Amaria, Jonathan L. Curry

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 14; DOI: 10.1186/s40425-018-0323-0
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 104; DOI: 10.1186/s40425-018-0417-8
Ipilimumab induced digital vasculitis
Amrita Padda, Elena Schiopu, Justin Sovich, Vincent Ma, Ajjai Alva, Leslie Fecher

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 12; DOI: 10.1186/s40425-018-0321-2
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
Ian Lai, Srividya Swaminathan, Virginie Baylot, Adriane Mosley, Renumathy Dhanasekaran, Meital Gabay, Dean W. Felsher

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 125; DOI: 10.1186/s40425-018-0431-x
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors
Edward Hammond, Nicole M. Haynes, Carleen Cullinane, Todd V. Brennan, Darryn Bampton, Paul Handley, Tomislav Karoli, Fleur Lanksheer, Liwen Lin, Yiping Yang, Keith Dredge

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 54; DOI: 10.1186/s40425-018-0363-5
Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement
Apostolia M. Tsimberidou, Laura A. Levit, Richard L. Schilsky, Steven D. Averbuch, Daniel Chen, John M. Kirkwood, Lisa M. McShane, Elad Sharon, Kathryn F. Mileham, Michael A. Postow

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 108; DOI: 10.1186/s40425-018-0426-7
Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition
Quaovi Sodji, Kandy Klein, Kavuri Sravan, Jigarkumar Parikh

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 62; DOI: 10.1186/s40425-017-0267-9
The immune system in cancer metastasis: friend or foe?
Louise M.E. Janssen, Emma E. Ramsay, Craig D. Logsdon, Willem W. Overwijk

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 79; DOI: 10.1186/s40425-017-0283-9
Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
Roger Sun, Francois-Xavier Danlos, Samy Ammari, Guillaume Louvel, Frédéric Dhermain, Stéphane Champiat, Olivier Lambotte, Eric Deutsch

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 96; DOI: 10.1186/s40425-017-0304-8
Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy
Rajeev Shrimali, Shamim Ahmad, Zuzana Berrong, Grigori Okoev, Adelaida Matevosyan, Ghazaleh Shoja E. Razavi, Robert Petit, Seema Gupta, Mikayel Mkrtichyan, Samir N. Khleif

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 64; DOI: 10.1186/s40425-017-0266-x

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages